Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control. Lymphoma comprises of a diverse group of blood cancers with different causes and treatment pathways. It is mainly categorized into two forms i.e., Hodgkin Lymphoma and non-Hodgkin Lymphoma (NHL).
The report details the trend, potential and market size of Lymphoma Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lymphoma Therapeuticsmarket, defines the market attractiveness level of Lymphoma Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lymphoma Therapeutics industry, describes the types of Lymphoma Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lymphoma Therapeutics market and the development prospects and opportunities of Lymphoma Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lymphoma Therapeutics market in Chapter 13.
By Player:
Novartis AG
Spectrum Pharmaceuticals, Inc
Bayer AG
Bristol Myers Squibb Company
Teva Pharmaceutical Industries Ltd
Janssen Pharmaceuticals, Inc
Takeda Pharmaceutical Company Limited
AstraZeneca
Kite Pharma, Inc / Gilead Sciences, Inc
By Type:
Targeted Therapy
Approved Drugs
Pipeline Drugs
Chemotherapy
Immunotherapy
By End-User:
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lymphoma Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lymphoma Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lymphoma Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lymphoma Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lymphoma Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Lymphoma Therapeutics Consumption (2017-2022)
-
7.2 United States Lymphoma Therapeutics Consumption (2017-2022)
-
7.3 Europe Lymphoma Therapeutics Consumption (2017-2022)
-
7.4 China Lymphoma Therapeutics Consumption (2017-2022)
-
7.5 Japan Lymphoma Therapeutics Consumption (2017-2022)
-
7.6 India Lymphoma Therapeutics Consumption (2017-2022)
-
7.7 South Korea Lymphoma Therapeutics Consumption (2017-2022)
8 Region and Country-wise Lymphoma Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Lymphoma Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Lymphoma Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Lymphoma Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Lymphoma Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Lymphoma Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Lymphoma Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Lymphoma Therapeutics Consumption Forecast (2022-2028)
9 Global Lymphoma Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Lymphoma Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Approved Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pipeline Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Lymphoma Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hodgkin Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non-Hodgkin Lymphoma Consumption and Growth Rate (2017-2022)
10 Global Lymphoma Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Lymphoma Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Approved Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Pipeline Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lymphoma Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hodgkin Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non-Hodgkin Lymphoma Consumption Forecast and Growth Rate (2022-2028)
11 Global Lymphoma Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lymphoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lymphoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lymphoma Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lymphoma Therapeutics Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Lymphoma Therapeutics Product and Service
-
14.2 Spectrum Pharmaceuticals, Inc
-
14.2.1 Spectrum Pharmaceuticals, Inc Company Details
-
14.2.2 Spectrum Pharmaceuticals, Inc Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Spectrum Pharmaceuticals, Inc Lymphoma Therapeutics Product and Service
-
14.3 Bayer AG
-
14.3.1 Bayer AG Company Details
-
14.3.2 Bayer AG Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer AG Lymphoma Therapeutics Product and Service
-
14.4 Bristol Myers Squibb Company
-
14.4.1 Bristol Myers Squibb Company Company Details
-
14.4.2 Bristol Myers Squibb Company Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol Myers Squibb Company Lymphoma Therapeutics Product and Service
-
14.5 Teva Pharmaceutical Industries Ltd
-
14.5.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.5.2 Teva Pharmaceutical Industries Ltd Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical Industries Ltd Lymphoma Therapeutics Product and Service
-
14.6 Janssen Pharmaceuticals, Inc
-
14.6.1 Janssen Pharmaceuticals, Inc Company Details
-
14.6.2 Janssen Pharmaceuticals, Inc Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Janssen Pharmaceuticals, Inc Lymphoma Therapeutics Product and Service
-
14.7 Takeda Pharmaceutical Company Limited
-
14.7.1 Takeda Pharmaceutical Company Limited Company Details
-
14.7.2 Takeda Pharmaceutical Company Limited Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Takeda Pharmaceutical Company Limited Lymphoma Therapeutics Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Lymphoma Therapeutics Product and Service
-
14.9 Kite Pharma, Inc / Gilead Sciences, Inc
-
14.9.1 Kite Pharma, Inc / Gilead Sciences, Inc Company Details
-
14.9.2 Kite Pharma, Inc / Gilead Sciences, Inc Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Kite Pharma, Inc / Gilead Sciences, Inc Lymphoma Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lymphoma Therapeutics
-
Figure Lymphoma Therapeutics Picture
-
Table Global Lymphoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lymphoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lymphoma Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lymphoma Therapeutics Consumption by Country (2017-2022)
-
Figure United States Lymphoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Lymphoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Lymphoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Lymphoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Lymphoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lymphoma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Lymphoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lymphoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lymphoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lymphoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lymphoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lymphoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Approved Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pipeline Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hodgkin Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Hodgkin Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Approved Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pipeline Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hodgkin Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Hodgkin Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lymphoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lymphoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Lymphoma Therapeutics Product and Service
-
Table Spectrum Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Spectrum Pharmaceuticals, Inc Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharmaceuticals, Inc Lymphoma Therapeutics Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Lymphoma Therapeutics Product and Service
-
Table Bristol Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Company Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Company Lymphoma Therapeutics Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Lymphoma Therapeutics Product and Service
-
Table Janssen Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals, Inc Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals, Inc Lymphoma Therapeutics Product and Service
-
Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Limited Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Lymphoma Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Lymphoma Therapeutics Product and Service
-
Table Kite Pharma, Inc / Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)
-
Table Kite Pharma, Inc / Gilead Sciences, Inc Lymphoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kite Pharma, Inc / Gilead Sciences, Inc Lymphoma Therapeutics Product and Service
-
